Introducing a Novel, First-in-Class Treatment for Primary Biliary Cholangitis (PBC)

Description

Join us for an informative product theater session on a recent FDA-approved treatment option for primary biliary cholangitis (PBC). Discover how this novel therapy may improve PBC outcomes for appropriate patients affected by this chronic liver disease.

Industry Supporter: Gilead Sciences, Inc.